Molly E Heft Neal, MD

Molly Heft Neal, MD
Clinical Assistant Professor of Otolaryngology-Head and Neck Surgery
Otolaryngology-Head and Neck Surgery Associate Chair At-Large
Otolaryngology Education Lead
Medical School
[email protected]
Available to mentor
Molly E Heft Neal, MD
Molly Heft Neal, MD
Clinical Assistant Professor
  • About
  • Qualifications
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    My clinical interests include the complex set of head and neck cancers comprised of HPV mediated oropharyngeal tumors, HPV negative tumors of the oropharynx, oral cavity, hypopharynx, and larynx as well as salivary gland tumors, sinonasal tumors and advanced cutaneous malignancies. I also specialize in robotic surgery for oropharyngeal tumors and in reconstructive surgery to restore form and function for patients undergoing cancer treatment.

    Qualifications

    • Resident Physician
      University of Michigan Medical School, Otolaryngology Head and Neck Surgery, Ann Arbor, United States
      2016 - 2022
      Residency
    • T32 Research Fellowship
      University of Michigan–Ann Arbor, Otolaryngology Head and Neck Surgery, Ann Arbor, United States
      2018 - 2020
      Residency
    • Fellowship
      Washington University in St. Louis School of Medicine, Head and Neck Surgery- Microvascular Reconstruction, St Louis, United States
      Postdoctoral Fellowship
    • MD, Doctor of Medicine
      University of Pittsburgh School of Medicine, Pittsburgh, United States
      2012 - 2016
    • BS, Biology with Honors
      Stanford University, Stanford, California, United States
      2007 - 2011

    Research Overview

    My research interests focus on translational questions in head and neck oncology. Specific areas of focus include understanding the how hypoxia drives radiation and chemoradiation failure in HPV-mediated oropharyngeal tumors and predictors of failure in larynx cancer in patients undergoing organ preserving therapy. Utilizing novel techniques including liquid biopsies and single cell sequencing, our group is striving to better understand the tumor microenvironment, tumor mutational signatures, and immune landscape that predict treatment failure. From a clinical perspective my research focuses on outcomes of HPV-mediated treatments in the setting of ongoing de-escalation trials to improve predictions of functional outcomes such as speech and swallowing after treatment.

    Recent Publications

    See All Publications
    • Journal Article
      Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.
      Flores G, Uaroon S, Garay JAR, Vanneste M, Riordan JD, Dupuy AJ, Thiel KW, Colling KE, Stipp CS, Lin L-C, Hollis B, Leidinger MR, Chen SJT, Graham LM, Knudtson KL, Chimenti MS, Ratcliff JA, Mehdi Z, McElliott MC, Anderson ER, Henry MD, Heft Neal ME, Brenner JC, Buchakjian MR. Cell Death Discov, 2026 Jun 20; DOI:10.1038/s41420-026-03202-y
      PMID: 42323321
    • Journal Article
      Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance
      Dalal PJ, Dermody SM, Ali H, Brummel C, Chad Brenner J, Buchakjian M, Casper KA, Chinn SB, Forner D, Hasan D, Malloy KM, McHugh J, Mierzwa M, Heft Neal ME, Prince ME, Shah J, Shuman AG, Stucken CL, Spector ME, Yalamanchi P, Worden FP, Swiecicki PL. Oto Open, 2026 Apr 1; 10 (2): DOI:10.1002/oto2.70259
    • Journal Article
      CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma
      Wang J, Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Gensterblum-Miller E, Zhai J, Jiang H, Swiecicki P, Buchakjian M, Heft Neal M, Chinn SB, Spector ME, Brenner JC. Head and Neck, 2026 Feb 1; 48 (2): 486 - 495. DOI:10.1002/hed.70048
      PMID: 40985049
    • Journal Article
      Validation of MyHPVscore: a high-performance HPV ctDNA lab developed test
      Mierzwa M, Brenner C. Journal of Molecular Diagnostics, 2026 Apr 30;
    • Journal Article
      Considerations and Cautions in Postoperative HPV Circulating Tumor DNA Kinetics
      Heft Neal ME, Bakst RL, Chai RL. JAMA Otolaryngology Head and Neck Surgery, 2025 Dec 11; 151 (12): 1124 - 1126. DOI:10.1001/jamaoto.2025.1612
      PMID: 40367056
    • Journal Article
      Tumor Hypoxia and CD8+ T-Cell Infiltration in Patients With Advanced Laryngeal Cancer
      Smith JD, Gensterblum-Miller E, Forner DWA, Yalamanchi P, Buchakjian MR, Chinn SB, Shuman AG, Casper KA, Malloy KM, Stucken CL, Mclean SA, Mierzwa ML, Shah J, Swiecicki PL, Worden FP, Prince MEP, Spector ME, Brenner JC, Heft Neal ME. Otolaryngology Head and Neck Surgery United States, 2025 Sep 1; 173 (3): 645 - 650. DOI:10.1002/ohn.1291
      PMID: 40323140
    • Journal Article
      Toward a Next-Generation Liquid Biopsy for HPV+ HNSCC: Opportunities, Challenges, and the Road Ahead
      Haring CT, Windon MJ, Heft-Neal ME, Chad Brenner J. Clinical Cancer Research, 2025 Aug 15; 31 (16): 3359 - 3361. DOI:10.1158/1078-0432.CCR-25-1488
      PMID: 40552930
    • Journal Article
      First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn
      Hasan D, Brenner JC, Swiecicki PL, Heft Neal ME. Translational Cancer Research, 2025 Jul 30; 14 (7): 3887 - 3891. DOI:10.21037/tcr-2025-782

    Featured News & Stories

    Smiling double portrait of David and Lori Liner standing close together.
    Philanthropy News

    Gratitude inspires gift to improve survivorship care

    Grateful for the care they received at Michigan Medicine, Lori and David Liner are supporting better outcomes for patients and survivors of head and neck cancer.